The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
931962111 9319621 11 F 2013 20160719 20130530 20160725 EXP US-GLAXOSMITHKLINE-A1013859A GLAXOSMITHKLINE 0.00 F Y 0.00000 20160725 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
931962111 9319621 1 PS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 48 NG/KG/MIN U N388 20444 49 DF POWDER FOR INFUSION
931962111 9319621 2 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U N848 20444 POWDER FOR INFUSION
931962111 9319621 3 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U P102 20444 POWDER FOR INFUSION
931962111 9319621 4 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U P828 20444 POWDER FOR INFUSION
931962111 9319621 5 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U R271A 20444 POWDER FOR INFUSION
931962111 9319621 6 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U S506 20444 POWDER FOR INFUSION
931962111 9319621 7 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U S706 20444 POWDER FOR INFUSION
931962111 9319621 8 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U S506 20444 POWDER FOR INFUSION
931962111 9319621 9 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 49 NG/KG/MIN CONTINUOUSLY U T662 20444 49 DF POWDER FOR INFUSION
931962111 9319621 10 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 49NG/KG/MIN (CONCENTRATION 60,000 NG/ML, PUMP RATE 75 ML/DAY, VIAL STRENGTH 1.5 MG) CO U V785 20444 POWDER FOR INFUSION
931962111 9319621 11 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 49 NG/KG/MIN (CONCENTRATION 60,000 NG/ML, PUMP RATE 75 ML/DAY, VIAL STRENGTH 1.5 MG) CO U Z606 0 SOLUTION FOR INJECTION
931962111 9319621 12 C LASIX FUROSEMIDE 1 U 0
931962111 9319621 13 C ADCIRCA TADALAFIL 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
931962111 9319621 1 Cor pulmonale chronic
931962111 9319621 2 Pulmonary hypertension
931962111 9319621 11 Pulmonary hypertension

Outcome of event

Event ID CASEID OUTC COD
931962111 9319621 HO
931962111 9319621 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
931962111 9319621 Abdominal pain
931962111 9319621 Ankle fracture
931962111 9319621 Balance disorder
931962111 9319621 Biopsy thyroid gland
931962111 9319621 Fall
931962111 9319621 Flushing
931962111 9319621 Foot fracture
931962111 9319621 Gallbladder disorder
931962111 9319621 Influenza
931962111 9319621 Irritable bowel syndrome
931962111 9319621 Ligament sprain
931962111 9319621 Lower respiratory tract infection
931962111 9319621 Malaise
931962111 9319621 Nasopharyngitis
931962111 9319621 Oral surgery
931962111 9319621 Sinusitis
931962111 9319621 Thyroid mass

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
931962111 9319621 1 19990809 0
931962111 9319621 2 19990809 0
931962111 9319621 3 19990809 0
931962111 9319621 4 19990809 0
931962111 9319621 5 19990809 0
931962111 9319621 6 19990809 0
931962111 9319621 7 19990809 0
931962111 9319621 8 19990809 0
931962111 9319621 11 19991105 0